Research Project

Project Title:

RTX4 Trial

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Hereditary glomerulopathies, Immune glomerulopathies

Project Summary:

Efficacy of humanized chimeric monoclonal anti-CD20 antibodies (Rituximab Biosimilar) in the treatment of childhood steroid-dependent nephrotic syndrome and development of cell biomarkers predicting outcome.

Lead principal investigator(s):



Marina Vivarelli, Rome
Francesco Emma, Rome

Project Period:

06/2019   -   06/2023


National funding agency

EudraCT Nr.:


« Back to research page